Compare IRWD & AMCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRWD | AMCX |
|---|---|---|
| Founded | 1998 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Cable & Other Pay Television Services |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 520.6M | 427.9M |
| IPO Year | 2010 | 2011 |
| Metric | IRWD | AMCX |
|---|---|---|
| Price | $5.45 | $7.92 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 5 | 5 |
| Target Price | $5.74 | ★ $6.50 |
| AVG Volume (30 Days) | ★ 7.4M | 363.7K |
| Earning Date | 02-26-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | $338,987,000.00 | ★ $2,316,303,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $37.22 | N/A |
| P/E Ratio | $29.98 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.53 | $5.41 |
| 52 Week High | $5.78 | $10.60 |
| Indicator | IRWD | AMCX |
|---|---|---|
| Relative Strength Index (RSI) | 77.47 | 29.79 |
| Support Level | $4.17 | $7.67 |
| Resistance Level | $4.80 | $8.61 |
| Average True Range (ATR) | 0.48 | 0.31 |
| MACD | 0.10 | -0.15 |
| Stochastic Oscillator | 81.68 | 13.87 |
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.
AMC Networks owns several linear pay-TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network, reached 60 million pay-TV households in the US at the end of 2024. The firm also had nearly 12.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.